Hyderabad-based pharma giant Dr Reddy’s Ltd finalizes its largest acquisition by buying British Haleon Plc’s non-US nicotine replacement therapy (NRT) business for GBP 458 million. The deal includes brands like Nicotinell, thriving in 31 countries, and may involve contingent payments up to GBP 42 million.
